Merger Roundup: August 26, 2013 - Presented by: The Aol. On Network

Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) announced they have approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FCX $ 10.885 0.70 ▲ 6.82%
ATVI $ 29.295 1.37 ▲ 4.89%
BAC $ 16.29 0.15 ▼ 0.91%
BTU $ 2.4099 0.13 ▲ 5.70%
FB $ 90.95 1.22 ▲ 1.36%
AAPL $ 112.35 0.57 ▼ 0.50%
PBR $ 5.885 0.16 ▲ 2.71%
QQQ $ 105.50 0.14 ▼ 0.13%

As of 8/28/2015, 09:59 AM